76. Pituitary gonadotropin secretion hyperthyroidism Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 29 / Drugs : 44 - (DrugBank : 14) / Drug target genes : 5 - Drug target pathways : 15
Pituitary gonadotropin secretion hyperthyroidism and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 76 | Pituitary gonadotropin secretion hyperthyroidism | - |
| 46 | Malignant rheumatoid arthritis | 6.000 |
| 65 | Primary immunodeficiency | 4.213 |
| 49 | Systemic lupus erythematosus | 4.203 |
| 2 | Amyotrophic lateral sclerosis | 4.191 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 4.182 |
| 113 | Muscular dystrophy | 2.757 |
| 299 | Cystic fibrosis | 2.722 |
| 96 | Crohn disease | 2.698 |
| 83 | Addison disease | 2.250 |
| 74 | Prolactin secreting pituitary adenoma | 1.781 |
| 64 | Thrombotic thrombocytopenic purpura | 1.781 |
| 285 | Fanconi anemia | 1.650 |
| 60 | Aplastic anemia | 1.607 |
| 63 | Idiopathic thrombocytopenic purpura | 1.600 |
| 3 | Spinal muscular atrophy | 1.585 |
| 53 | Sjogren syndrome | 1.582 |
| 86 | Pulmonary arterial hypertension | 1.545 |
| 191 | Werner syndrome | 1.000 |